Sprout Health
LegitScript-certified compounded semaglutide with a real brand-name Wegovy/Zepbound path and a near-frictionless, often visit-free start.
Compounded semaglutide from $149/mo and tirzepatide from $199/mo (company-stated); a real brand-name Wegovy/Zepbound path is also offered
Tirzepatide: From $199/mo (company-stated)
Full write-up — how it works, strengths and trade-offs
Sprout Health is a LegitScript-certified telehealth brand that pairs a low compounded entry point with a genuine brand-name route. Compounded semaglutide starts at $149/month and tirzepatide at $199/month (company-stated) and, unlike most compounders, it also offers a real brand-name Wegovy/Zepbound path. Intake is deliberately low-friction: no labs are required and often no telehealth visit either, so the start is close to frictionless. The trade-offs are transparency and scope — the compounded product is 503A-style and not FDA-approved, it is injectable only with no oral route, there is no named medical director, and state availability is gated behind a quiz.
Strengths
- LegitScript-certified with a listed address and contact line
- Low compounded entry — $149 semaglutide / $199 tirzepatide — plus a genuine brand-name Wegovy/Zepbound route
- Low-friction intake: no labs and often no telehealth visit required
Trade-offs
- Compounded semaglutide is not FDA-approved
- Injectable only — no oral or sublingual route
- Thin transparency — no named medical director, and state availability is quiz-gated
- No specific compounding pharmacy is named, and Sprout's own page never states a facility class — it says only that medication is “prepared by licensed U.S. pharmacies”